Nov 11, 2019 06:07AM
Nov 11, 2019 06:00AM
Nov 1, 2019 08:00AM
Aug 7, 2019 04:05PM
Jul 24, 2019 08:00AM
Jun 4, 2019 08:14AM
Jun 4, 2019 08:00AM Foamix Announces Publication of Phase 3 FMX101 Acne Study in Journal of American Academy of Dermatology
May 7, 2019 04:40PM
May 7, 2019 04:21PM
Apr 24, 2019 08:00AM
Feb 28, 2019 04:40PM
Feb 28, 2019 04:01PM
Feb 14, 2019 08:00AM
Nov 27, 2018 08:00AM Foamix Announces Appointment of Matt Wiley as Chief Commercial Officer
Nov 7, 2018 04:05PM
Nov 7, 2018 06:16AM
Nov 7, 2018 06:00AM
Oct 29, 2018 08:00AM
Oct 12, 2018 08:00AM
Oct 11, 2018 04:05PM
Oct 1, 2018 08:05AM Foamix (FOMX) Announces Additional Positive Topline Results from Third Phase 3 Trial Evaluating FMX101
Oct 1, 2018 08:00AM
Sep 18, 2018 10:55AM
Sep 14, 2018 06:23AM
Sep 13, 2018 07:06PM
Sep 12, 2018 04:33PM
Sep 12, 2018 04:31PM
Sep 11, 2018 05:03PM Foamix (FOMX) Says Third Phase 3 Trial of FMX101 for Acne Met Co-primary Endpoints
Sep 11, 2018 05:00PM
Aug 8, 2018 04:46PM
Aug 8, 2018 04:01PM
Aug 1, 2018 08:00AM
Jun 27, 2018 09:04AM
Jun 27, 2018 08:07AM
Jun 27, 2018 08:00AM Foamix Announces Dosing of Last Patient in Phase 3 Rosacea Studies for Minocycline Foam FMX103
May 8, 2018 05:04PM
May 7, 2018 08:00AM
Apr 24, 2018 08:00AM
Apr 16, 2018 08:00AM
Feb 28, 2018 08:00AM
Feb 13, 2018 08:00AM
Jan 4, 2018 08:04AM Foamix (FOMX) Reports Phase 3 Open-Label Safety Extension Evaluating FMX-101 Topical Minocycline Foam for Treatment up to 1 Year
Jan 4, 2018 08:00AM
Jan 3, 2018 08:00AM
Nov 15, 2017 07:00AM
Nov 1, 2017 08:00AM
Aug 8, 2017 04:01PM
Aug 3, 2017 08:00AM
Jul 26, 2017 08:00AM Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for August 9
Jun 29, 2017 08:08AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All